Potential of new BCMA-targeting therapies in overcoming resistance in multiple myeloma
{{output}}
Introduction: B-cell maturation antigen is an important therapeutic target in multiple myeloma. Several chimeric antigen receptor T-cell (CAR-T) products, bispecific T-cell engagers, and antibody-drug conjugates targeting BCMA ar... ...
